SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after announcing record-high December and fourth-quarter 2025 vehicle deliveries, meeting the high end of its guidance and nearing one million cumulative vehicles overall. This strong performance, coupled with China's extended EV purchase tax benefits favoring battery-swapping models, has ignited community discussions about potential Q4 profitability and a bright 2026 outlook for the multi-brand EV maker. Many investors are optimistic, comparing NIO's sales favorably against peers and anticipating significant upside despite recent price volatility.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its highly engaged community actively champions the "OG meme" narrative of Rage Comics, viewing it as the foundational "meme reset." This dedicated base is passionately building out an ecosystem with tools like RageMaker and RageGames, expressing strong conviction for significant long-term growth and widespread recognition as they aim to lead the next major meme coin cycle.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is experiencing high trading volume driven by news of a strategic manufacturing partnership to scale production of its fingerprinting drug screening reader. This announcement has ignited a fierce debate within the trading community, with many anticipating a short squeeze due to the stock's low float, while others express caution regarding potential dilution and pump-and-dump dynamics.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is trending as its community grapples with the impact of a recent dividend distribution, leading to widespread confusion and frustration over its sharp decline. Many investors are questioning why the 2x leveraged ETF is not tracking its underlying asset, SMCI, as expected, fueling concerns about decay and the potential for a reverse split. While some traders see the current suppressed levels as a buying opportunity, others warn of the significant volatility and risks inherent in such leveraged products.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems (OSS) is trending due to the definitive sale of its Bressner Technology subsidiary for $22.4 million, a strategic move by management to focus on its higher-growth Edge AI compute business and strengthen its balance sheet. The community is actively discussing this, alongside strong anticipation for an imminent multi-hundred-million dollar US Army situational awareness contract, seeing OSS as significantly undervalued within the defense and AI sectors.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending after its relacorilant drug for Cushing's syndrome received a Complete Response Letter from the FDA, requesting additional efficacy evidence despite a successful pivotal trial, causing a sharp stock decline. Many investors view this over 50% drop as an overreaction, highlighting the company's established, revenue-generating drug Korlym and its broader pipeline. Amidst year-end tax-loss selling and wider biotech sector volatility, community discussion centers on the potential for regulatory resolution versus further valuation adjustments.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

ASP Isotopes is trending amid recent regulatory approvals for a key acquisition and an analyst firm initiating coverage with an "Overweight" rating. While some investors voice frustration over past delays in commercial revenue and management communication, a significant portion of the community maintains strong conviction in the long-term potential of its specialized isotope technology for critical sectors including advanced energy, medical applications, and next-generation computing. The conversation highlights a divide between those concerned about execution timelines and those focused on strategic asset accumulation and the company's unique market position.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai is trending due to its recent partnership with Google Cloud for the Agentic Interop Summit, signaling increased recognition and strategic positioning within the AI ecosystem. The community is also reacting to Ocean Protocol's departure from the ASI Alliance, which has led to a significant FET token burn, viewed by many as a deflationary catalyst. Despite past volatility, investors are actively discussing Fetch.ai's potential for real-world AI agent adoption and its perceived undervaluation within the broader AI crypto sector.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group (DJT) is actively discussed after announcing plans to distribute new digital tokens to shareholders via Crypto.com. This move is generating polarized community reactions, with some investors seeing it as a potential short squeeze catalyst and shareholder reward, while others view the non-transferable tokens as a "worthless" incentive or a "pump and dump" scheme. The debate reflects ongoing concerns about the company's financial performance and future strategy.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending significantly following the FDA's Complete Response Letter to competitor Corcept Therapeutics for its Cushing's syndrome treatment. This outcome is widely viewed by the community and analysts as a "massive tailwind" for Xeris's Recorlev, strengthening its market position in a growing multi-billion dollar sector. Investors are actively discussing this enhanced competitive moat and the promising future of its XP-8121 pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ares Management LLC Has $87.48 Million Position in Global Business Travel Group, Inc. $GBTG

Ares Management LLC boosted its holdings in shares of Global Business Travel Group, Inc. (NYSE:GBTG - Free Report) by 21.8% during the 2nd quarter, according to its most recent disclosure with the...

Chief Financial Officer Of Global Business Travel Makes $1.22M Sale

Global Business Travel Group, Inc. (NYSE:GBTG) Receives Average Recommendation of "Hold" from Brokerages

Shares of Global Business Travel Group, Inc. (NYSE:GBTG - Get Free Report) have earned a consensus recommendation of "Hold" from the six ratings firms that are covering the firm, MarketBeat reports...

Global Business Travel Group (NYSE:GBTG) Shares Gap Up - What's Next?

Global Business Travel Group (NYSE:GBTG) Shares Gap Up - Here's Why...

<ul class="summary-bullets"><li>The Bloomberg News report stated that the company’s deliberations are ongoing and there’s no certainty that the efforts will lead to a deal.</li><li>The stock closed higher at $7.32 on Monday, giving it a market capitalization of over $3.7 billion.</li><li>For the third quarter, the firm’s revenue rose 13% to $674 million, with travel segment revenue increasing 10% due to the CWT Travels acquisition.</li></ul>Global Business Travel Group is expected to draw retail attention on Tuesday after a report said that the business-travel platform is weighing a sale.The firm, which spun out of American Express, is working with advisers on a sale that would likely draw the interest from other corporate-focused travel platforms and private equity firms, Bloomberg News reported, citing people familiar with the matter.The report further stated that the company’s deliberations are ongoing and there’s no certainty that the efforts will lead to a deal. The firm, known as Amex GBT, could even choose to remain independent.<h2 class="st-heading-2">What Are Stocktwits Users Thinking?</h2>Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/GBTG">Amex GBT </a>moved to ‘bullish’ territory from ‘neutral’ a day ago, while retail chatter jumped to ‘extremely high.’<figure class="image"><img style="aspect-ratio:722/93;" src="https://news.stocktwits-cdn.com/GBTG_nov_25_JPG_41fb8ff090.webp" alt="GBTG’s Sentiment Meter and Message Volume as of 05:30 a.m. ET on Nov. 25, 2025 | Source: Stocktwits" width="722" height="93"><figcaption>GBTG’s Sentiment Meter and Message Volume as of 05:30 a.m. ET on Nov. 25, 2025 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Takeover Talks Emerge Amid Stock Underperformance</h2>Amex GBT’s shares have fallen by over 21.4% this year. The stock closed higher at $7.32 on Monday, giving it a market capitalization of over $3.7 billion. Amex GBT’s separation from American Express began in 2014, when the U.S. payments giant sold a stake in the business to a group that included Certares. The report stated that American Express remains Amex GBT’s largest shareholder, holding a 30.1% stake.The New York-based firm went public through a special-purpose acquisition company backed by Apollo Global Management. In September, the firm acquired rival CWT Travels for $540 million, a deal that invited scrutiny from the U.S. and UK antitrust regulators.For the third quarter, the firm’s revenue rose 13% to $674 million, with travel segment revenue increasing 10% due to the CWT acquisition.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-is-aerospace-supplier-woodward-stock-gaining-6-premarket/cL52QGAREX0">Why Is Aerospace Supplier Woodward Stock Gaining 6% Premarket?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

Amex GBT Reportedly Mulls Potential Sale, Retail Turns Bullish

The firm, which spun out of American Express, is reportedly working with advisers on a sale that is likely to draw interest from other corporate-focused travel platforms and private equity firms.

Equity

Neo Ivy Capital Management Acquires 36,824 Shares of Global Business Travel Group, Inc. $GBTG

Neo Ivy Capital Management lifted its holdings in Global Business Travel Group, Inc. (NYSE:GBTG - Free Report) by 926.2% in the second quarter, according to the company in its most recent disclosure...

Global Business Travel Group, Inc. (NYSE:GBTG) Given Average Recommendation of "Hold" by Brokerages

Global Business Travel Group, Inc. (NYSE:GBTG - Get Free Report) has earned an average rating of "Hold" from the five ratings firms that are covering the stock, MarketBeat reports. Two research...

Global Business Travel Group (NYSE:GBTG) Rating Lowered to "Strong Sell" at Zacks Research

Zacks Research downgraded Global Business Travel Group from a "hold" rating to a "strong sell" rating in a report on Wednesday...

Global Business Travel Group (NYSE:GBTG) Posts Quarterly Earnings Results, Misses Expectations By $0.09 EPS

Global Business Travel Group (NYSE:GBTG - Get Free Report) announced its earnings results on Monday. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.02 by...

Global Business Travel Group, Inc. (GBTG) Reports Q3 Loss, Tops Revenue Estimates

Global Business Travel Group, Inc. (GBTG) delivered earnings and revenue surprises of -450.00% and +9.35%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Global Business Travel Group, Inc. operates as a business-to-business travel platform. It provides software and services to manage travel, expenses, and meetings and events for companies of all sizes. The firm offers business travel solutions, simplified travel management, and business consulting services. It also provides global service solutions, automated booking, diverse options, system integration and specialized traveler care. It offers Expert Auditor, Expert Care and the Business Travel App. The Expert Auditor travel program guides travelers to company-approved providers and destinations before they book a trip. Expert Care is a global proactive service featuring risk alerts and direct communications during a disruption. The company was founded in 2014 and is headquartered in New York, NY.

Current Price	$7.65
Prev Close	$7.79
Open	$7.74
Dividend Yield	0.00%
50-Day Moving Average	$7.71
Beta	1.01
Avg. Volume	1.54M
PE Ratio	341.52

52-Week High	$9.34
52-Week Low	$5.78
Market Capitalization	$4.08B
EPS (Annual)	-$0.2982
Price to Book	2.63
Revenue Per Employee	$134,611.11
Enterprise Value/EBITDA	N/A

GBTG
Global Business Travel Group Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GBTG News

GBTGGlobal Business Travel Group Inc - Ordinary Shares - Class A